Quick answer
Albemarle Corporation (ALB) reported revenue of $5.14B and net loss of $510.6M for the fiscal year ended 2025-12-31, down 4.4% from $5.38B the year before, per its 10-K filed with the SEC on 2026-02-11. Long-term debt stood at $3.19B.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $5.14B | -$510.6M | $3.19B |
| 2024 (FY ending 2024-12-31) | $5.38B | -$1.18B | $3.52B |
| 2023 (FY ending 2023-12-31) | $9.62B | $1.57B | $4.17B |
| 2022 (FY ending 2022-12-31) | $7.32B | $2.69B | $3.22B |
| 2021 (FY ending 2021-12-31) | $3.33B | $123.7M | $2.39B |
| 2020 (FY ending 2020-12-31) | $3.13B | $375.8M | $3.57B |
| 2019 (FY ending 2019-12-31) | $3.59B | $533.2M | $3.05B |
| 2018 (FY ending 2018-12-31) | $3.37B | $693.6M | $1.71B |
| 2017 (FY ending 2017-12-31) | $3.07B | $54.9M | $1.84B |
| 2016 (FY ending 2016-12-31) | $2.68B | $643.7M | $2.37B |
Related
- AJG revenue, net income and debt history (Arthur J. Gallagher & Co.)
- AKAM revenue, net income and debt history (Akamai Technologies, Inc)
- ALAB revenue, net income and debt history (Astera Labs, Inc.)
- ALGN revenue, net income and debt history (Align Technology, Inc.)
- ALL revenue, net income and debt history (Allstate Corp)
- ALLE revenue, net income and debt history (Allegion plc)
- ALLY revenue, net income and debt history (Ally Financial Inc.)
- ALNY revenue, net income and debt history (Alnylam Pharmaceuticals, Inc.)
Last updated 2026-10-16. Data only, not financial or tax advice.